Literature DB >> 16682512

Serum C-reactive protein as a marker for wellness assessment.

Pai C Kao1, Shu-Chu Shiesh, Ta-Jen Wu.   

Abstract

C-reactive protein (CRP), a nonspecific inflammatory marker, is widely used to monitor treatment of cardiovascular diseases (high serum CRP levels indicate poor outcome of heart disease). A healthy lifestyle decreases serum CRP levels, while obesity, physical inactivity, and smoking increase them. CRP, a stable pentameric protein, has a half-life of 19 hr, is not subject to diurnal variation, and can serve as a marker of wellness and a candidate for future direct access testing for people monitoring their health after adopting a healthier lifestyle. The CRP level may be influenced more by lifestyle than by genetics. Monozygotic twins may not have the same CRP level; within each twin pair, the one with higher adiposity generally has a higher CRP level than the one with low adiposity. Chronic diseases generally have a lower prevalence among Asians than among Westerners. Asians also have lower CRP levels than Westerners. In large population studies, the median CRP level of Asians is only one-tenth that of Westerners. Is there a factor in the lifestyle or diet of Asians that accounts for lower CRP levels? For example, a statin inhibitor of cholesterol synthesis occurs in red yeast rice, an important component of the Asian diet. In summary, CRP is a marker for monitoring cardiovascular therapy and assessing the wellness of the general population. Through improving health and preventing disease, CRP testing may help lower a nation's health costs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682512

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  37 in total

1.  Systemic inflammation moderates the association of prior concussion with hippocampal volume and episodic memory in high school and collegiate athletes.

Authors:  Benjamin L Brett; Jonathan Savitz; Morgan Nitta; Lezlie España; T Kent Teague; Lindsay D Nelson; Michael A McCrea; Timothy B Meier
Journal:  Brain Behav Immun       Date:  2020-07-24       Impact factor: 7.217

Review 2.  Acute phase response in animals: a review.

Authors:  Carolyn Cray; Julia Zaias; Norman H Altman
Journal:  Comp Med       Date:  2009-12       Impact factor: 0.982

3.  Association of in vivo β-adrenergic receptor sensitivity with inflammatory markers in healthy subjects.

Authors:  Frank Euteneuer; Paul J Mills; Winfried Rief; Michael G Ziegler; Joel E Dimsdale
Journal:  Psychosom Med       Date:  2012-02-24       Impact factor: 4.312

4.  Safety, tolerability, pharmacokinetics and pharmacodynamics of losmapimod following a single intravenous or oral dose in healthy volunteers.

Authors:  April M Barbour; Lea Sarov-Blat; Gengqian Cai; Michael J Fossler; Dennis L Sprecher; Johann Graggaber; Adam T McGeoch; Jo Maison; Joseph Cheriyan
Journal:  Br J Clin Pharmacol       Date:  2013-07       Impact factor: 4.335

5.  A combination of palm oil tocotrienols and citrus peel polymethoxylated flavones does not influence elevated LDL cholesterol and high-sensitivity C-reactive protein levels.

Authors:  J P Schuchardt; S Heine; A Hahn
Journal:  Eur J Clin Nutr       Date:  2015-04-01       Impact factor: 4.016

6.  Allostatic load and heart rate variability as health risk indicators.

Authors:  Margaretha Viljoen; Nicolaas Claassen
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

7.  Developmental exposure of mice to TCDD elicits a similar uterine phenotype in adult animals as observed in women with endometriosis.

Authors:  Tultul Nayyar; Kaylon L Bruner-Tran; Dagmara Piestrzeniewicz-Ulanska; Kevin G Osteen
Journal:  Reprod Toxicol       Date:  2006-09-30       Impact factor: 3.143

8.  Vitamin B-6 intake is inversely related to, and the requirement is affected by, inflammation status.

Authors:  Martha Savaria Morris; Lydia Sakakeeny; Paul F Jacques; Mary Frances Picciano; Jacob Selhub
Journal:  J Nutr       Date:  2009-11-11       Impact factor: 4.798

9.  Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk.

Authors:  Satish A Eraly; Caroline M Nievergelt; Adam X Maihofer; Donald A Barkauskas; Nilima Biswas; Agorastos Agorastos; Daniel T O'Connor; Dewleen G Baker
Journal:  JAMA Psychiatry       Date:  2014-04       Impact factor: 21.596

10.  Plasma CRP levels in premenopausal women with major depression: a 12-month controlled study.

Authors:  G Cizza; F Eskandari; M Coyle; P Krishnamurthy; E C Wright; S Mistry; G Csako
Journal:  Horm Metab Res       Date:  2009-04-30       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.